Press release MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight administration and weight loss For the first time in britain, obese patients and people who are overweight with weight-similar health problems could now have entry to Mounjaro, currently used for Form two diabetic issues, to help you control their weight https://troydxvjp.canariblogs.com/not-known-facts-about-weight-loss-medication-injection-47900915